<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="1-part\PMC6409754\results\search\disease\results.xml">
  <result pre="despite the advances in the development and wide use of" exact="influenza" post="vaccines. Vaccination with traditional inactivate influenza vaccines (IIV) or"/>
  <result pre="and wide use of influenza vaccines. Vaccination with traditional inactivate" exact="influenza" post="vaccines (IIV) or live-attenuated influenza vaccines (LAIV) remains the"/>
  <result pre="vaccines. Vaccination with traditional inactivate influenza vaccines (IIV) or live-attenuated" exact="influenza" post="vaccines (LAIV) remains the main strategy in the control"/>
  <result pre="seasonal epidemics, but it does not offer protection against new" exact="influenza" post="viruses with pandemic potential, those that have shifted. Moreover,"/>
  <result pre="have shifted. Moreover, the continual antigenic drift of seasonal circulating" exact="influenza" post="viruses, causing an antigenic mismatch that requires yearly reformulation"/>
  <result pre="causing an antigenic mismatch that requires yearly reformulation of seasonal" exact="influenza" post="vaccines, seriously compromises vaccine efficacy. Therefore, the quick optimization"/>
  <result pre="efficacy. Therefore, the quick optimization of vaccine production for seasonal" exact="influenza" post="and the development of new vaccine approaches for pandemic"/>
  <result pre="pandemic viruses is still a challenge for the prevention of" exact="influenza" post="infections. Moreover, recent reports have questioned the effectiveness of"/>
  <result pre="the current LAIV because of limited protection, mainly against the" exact="influenza" post="A virus (IAV) component of the vaccine. Although the"/>
  <result pre="a key advance in the rapid generation of recombinant attenuated" exact="influenza" post="viruses that can be used for the development of"/>
  <result pre="of these new LAIVs reveal their possible implementation in combating" exact="influenza" post="infections. However, efforts by vaccine companies and government agencies"/>
  <result pre="approving, respectively, these new vaccine methodologies for the control of" exact="influenza" post="infections. influenza virus influenza vaccines influenza inactivated vaccine (IIV)"/>
  <result pre="these new vaccine methodologies for the control of influenza infections." exact="influenza" post="virus influenza vaccines influenza inactivated vaccine (IIV) live-attenuated influenza"/>
  <result pre="vaccine methodologies for the control of influenza infections. influenza virus" exact="influenza" post="vaccines influenza inactivated vaccine (IIV) live-attenuated influenza vaccine (LAIV)"/>
  <result pre="for the control of influenza infections. influenza virus influenza vaccines" exact="influenza" post="inactivated vaccine (IIV) live-attenuated influenza vaccine (LAIV) influenza reverse"/>
  <result pre="infections. influenza virus influenza vaccines influenza inactivated vaccine (IIV) live-attenuated" exact="influenza" post="vaccine (LAIV) influenza reverse genetics recombinant influenza virus immunogenicity"/>
  <result pre="influenza vaccines influenza inactivated vaccine (IIV) live-attenuated influenza vaccine (LAIV)" exact="influenza" post="reverse genetics recombinant influenza virus immunogenicity protection efficacy 1."/>
  <result pre="vaccine (IIV) live-attenuated influenza vaccine (LAIV) influenza reverse genetics recombinant" exact="influenza" post="virus immunogenicity protection efficacy 1. Introduction 1.1. Influenza A"/>
  <result pre="is attached to galactose by an α2,3 linkage, while human" exact="influenza" post="viruses preferentially bind the sialic acid attached to galactose"/>
  <result pre="States (US), the Advisory Committee for Immunization Practices (ACIP) recommends" exact="influenza" post="vaccination every year for all persons older than six"/>
  <result pre="world by using data obtained from more than 130 national" exact="influenza" post="centers that are located in over 100 countries to"/>
  <result pre="perform the correct update of the vaccine for the following" exact="influenza" post="season [36,37]. Three types of vaccines have been approved"/>
  <result pre="for use in the human population: recombinant viral HAs, inactivated" exact="influenza" post="vaccine (IIVs), and live attenuated influenza vaccines (LAIVs) [38]."/>
  <result pre="recombinant viral HAs, inactivated influenza vaccine (IIVs), and live attenuated" exact="influenza" post="vaccines (LAIVs) [38]. The IIV, which was introduced and"/>
  <result pre="1940s, is the most common vaccine for the treatment of" exact="influenza" post="virus infections. IIVs are produced by co-infection of embryonated"/>
  <result pre="60–90% effective in preventing the morbidity and mortality associated with" exact="influenza" post="infection [44,45,46] by inducing a strong humoral immune response"/>
  <result pre="are intranasally administrated and they mimic the natural route of" exact="influenza" post="infection. They induce broader and more robust immune responses"/>
  <result pre="naive populations and provide cross-protection against heterosubtypic strains, including pandemic" exact="influenza" post="viruses. This LAIV protection profile is a highly desirable"/>
  <result pre="LAIV protection profile is a highly desirable requisite for effective" exact="influenza" post="vaccine candidates [54,55]. The strategy to produce LAIVs is"/>
  <result pre="Donor Virus (MDV) (Figure 3). The segmented nature of the" exact="influenza" post="virus genome allows for the generation of a reassortant"/>
  <result pre="avoiding viral replication in the warmer lower respiratory tract, where" exact="influenza" post="virus infection causes diseases [62]. Due to the fact"/>
  <result pre="[64]. Currently, two IAV subtypes (H1N1 and H3N2) and two" exact="influenza" post="B virus (IBV) lineages (Victoria and Yamagata) are co-circulating"/>
  <result pre="are co-circulating in humans and they are responsible for seasonal" exact="influenza" post="epidemics. The first LAIV (FluMist; MedImmune) that was approved"/>
  <result pre="LAIV Approaches to Combat Influenza Infections In the past decades," exact="influenza" post="vaccine preparation has evolved to ensure effective protection against"/>
  <result pre="should not be used during the subsequent 2016–2017 and 2017–2018" exact="influenza" post="seasons [34,86]. However, for the 2018–2019 influenza season, the"/>
  <result pre="2016–2017 and 2017–2018 influenza seasons [34,86]. However, for the 2018–2019" exact="influenza" post="season, the use of the LAIV has again been"/>
  <result pre="has several advantages over the IIV for the control of" exact="influenza" post="viral infections. These include, among others, the intranasal route"/>
  <result pre="and production for the treatment of seasonal and potential pandemic" exact="influenza" post="viral infections in humans. 1.4. Reverse Genetics Techniques for"/>
  <result pre="of Novel Influenza Vaccines Because of the changing nature of" exact="influenza" post="virus, vaccine production to develop high-yield strains as vaccine"/>
  <result pre="high-yield strains as vaccine components is a constant challenge. Manufacturing" exact="influenza" post="vaccines usually take around four to five months to"/>
  <result pre="into research has advanced our understanding of the biology of" exact="influenza" post="virus, including the mechanisms that are involved in viral"/>
  <result pre="Reverse genetics strategies have also enabled the modification of the" exact="influenza" post="viral genome to generate recombinant viruses expressing foreign proteins"/>
  <result pre="plasmid-based reverse genetics approaches have been developed to generate recombinant" exact="influenza" post="viruses [114]. Currently, the most common method delivers eight"/>
  <result pre="Currently, the generation of recombinant viruses for the development of" exact="influenza" post="vaccines for human use in the US and Europe"/>
  <result pre="[118,119,120,121,122]. Although the FDA approved the cell-based production method of" exact="influenza" post="vaccines in 2012, the global-scale infrastructure for manufacturing the"/>
  <result pre="the global-scale infrastructure for manufacturing the required amount of cell-based" exact="influenza" post="vaccines does not currently exist [123]. In fact, the"/>
  <result pre="does not currently exist [123]. In fact, the majority of" exact="influenza" post="vaccines that are currently commercialized by licensed manufactures are"/>
  <result pre="[124]. One of the reasons why the traditional method for" exact="influenza" post="vaccine production by co-infection of using chicken embryonated eggs"/>
  <result pre="aspect for the vaccine manufacturing process [40,125]. Unfortunately, most current" exact="influenza" post="viruses do not grow well in eggs and this"/>
  <result pre="this affects the efficiency of the traditional reassortment method. Therefore," exact="influenza" post="plasmid-based reverse genetics (Figure 4) represent a better, faster,"/>
  <result pre="approaches represent an excellent alternative to the traditional method for" exact="influenza" post="vaccine production and it might become the method of"/>
  <result pre="of the viral NS1 protein to protect against H3N8 canine" exact="influenza" post="virus (CIV) [138]. Interestingly, in vitro, these viruses replicated"/>
  <result pre="of the virus in vivo in a mouse model of" exact="influenza" post="infection and ex vivo in canine tracheal explants, with"/>
  <result pre="develop a platform to allow for the efficient growth of" exact="influenza" post="H3 subtypes in eggs, the authors also generated viruses"/>
  <result pre="vaccine candidates for their safe implementation as immunogenic and protective" exact="influenza" post="vaccines. 2.4. LAIVs Based on the Modification of the"/>
  <result pre="be used to develop both monovalent and/or bivalent vaccines against" exact="influenza" post="strains or different respiratory pathogens. In order to study"/>
  <result pre="pathogenic human or avian IAVs, such as the 1918 Spanish" exact="influenza" post="(A/Brevig Mission/18 H1N1) and HPAIV (A/Vietnam/1203/04 H5N1) [106]. In"/>
  <result pre="antigen from another pathogen, Masic et al. generated a swine" exact="influenza" post="virus (SIV) by fusing the H3 HA ectodomain from"/>
  <result pre="a monovalent M2SR-based LAIV based on 5 gene segments from" exact="influenza" post="PR8 and the HA and NA glycoproteins from an"/>
  <result pre="the primary and most cost-effective strategy to prevent and control" exact="influenza" post="infections in human and animal populations. The continued evaluation"/>
  <result pre="continued evaluation of the safety, immunogenicity, and effectiveness of seasonal" exact="influenza" post="vaccines is needed to ensure low rates of influenza"/>
  <result pre="seasonal influenza vaccines is needed to ensure low rates of" exact="influenza" post="infection among children and adults. However, efforts should be"/>
  <result pre="provide better protection than their IIV counterparts. However, in past" exact="influenza" post="seasons, a suboptimal protection was observed mainly against the"/>
  <result pre="Although the LAIV was approved for use during the 2018–2019" exact="influenza" post="season, the reduced effectiveness of the quadrivalent LAIV remains"/>
  <result pre="of preventing or ameliorating the effects of seasonal and/or pandemic" exact="influenza" post="by providing broader and more long-lasting immune protection than"/>
  <result pre="strategic plan that was recently proposed for developing a universal" exact="influenza" post="vaccine [224]. This universal vaccine should be at least"/>
  <result pre="update on the progress that has been made in the" exact="influenza" post="vaccination field in the last five years to improve"/>
  <result pre="We want to thank all the work conducted by the" exact="influenza" post="researchers reference in this document that has contributed to"/>
  <result pre="a new approach for the development of LAIV. Research on" exact="influenza" post="in our laboratory is partially supported by the New"/>
  <result pre="the viral life cycleYale J. Biol. Med.20098215315920027280 5.BouvierN.M.PaleseP.The biology of" exact="influenza" post="virusesVaccine200826Suppl. 4D49D5310.1016/j.vaccine.2008.07.03919230160 6.NeumannG.BrownleeG.G.FodorE.KawaokaY.Orthomyxovirus replication, transcription, and polyadenylationCurr. Top. Microbiol."/>
  <result pre="replication, transcription, and polyadenylationCurr. Top. Microbiol. Immunol.200428312114315298169 7.FujiiY.GotoH.WatanabeT.YoshidaT.KawaokaY.Selective incorporation of" exact="influenza" post="virus RNA segments into virionsProc. Natl. Acad. Sci. USA20031002002200710.1073/pnas.043777210012574509"/>
  <result pre="8.ImaiM.KawaokaY.The role of receptor binding specificity in interspecies transmission of" exact="influenza" post="virusesCurr. Opin. Virol.2012216016710.1016/j.coviro.2012.03.00322445963 9.NichollsJ.M.ChanR.W.RussellR.J.AirG.M.PeirisJ.S.Evolving complexities of influenza virus and"/>
  <result pre="interspecies transmission of influenza virusesCurr. Opin. Virol.2012216016710.1016/j.coviro.2012.03.00322445963 9.NichollsJ.M.ChanR.W.RussellR.J.AirG.M.PeirisJ.S.Evolving complexities of" exact="influenza" post="virus and its receptorsTrends Microbiol.20081614915710.1016/j.tim.2008.01.00818375125 10.HarrisonS.C.Viral membrane fusionNat. Struct."/>
  <result pre="its receptorsTrends Microbiol.20081614915710.1016/j.tim.2008.01.00818375125 10.HarrisonS.C.Viral membrane fusionNat. Struct. Mol. Biol.20081569069810.1038/nsmb.145618596815 11.Resa-InfanteP.JorbaN.ColomaR.OrtinJ.The" exact="influenza" post="virus RNA synthesis machine: Advances in its structure and"/>
  <result pre="13.WiseH.M.HutchinsonE.C.JaggerB.W.StuartA.D.KangZ.H.RobbN.SchwartzmanL.M.KashJ.C.FodorE.FirthA.E.et al.Identification of a novel splice variant form of the" exact="influenza" post="A virus M2 ion channel with an antigenically distinct"/>
  <result pre="with an antigenically distinct ectodomainPLoS Pathog.20128e100299810.1371/journal.ppat.100299823133386 14.PatersonD.FodorE.Emerging roles for the" exact="influenza" post="A virus nuclear export protein (NEP)PLoS Pathog.20128e100301910.1371/journal.ppat.100301923236273 15.HaiR.SchmolkeM.VargaZ.T.ManicassamyB.WangT.T.BelserJ.A.PearceM.B.Garcia-SastreA.TumpeyT.M.PaleseP.PB1-F2 expression"/>
  <result pre="protein (NEP)PLoS Pathog.20128e100301910.1371/journal.ppat.100301923236273 15.HaiR.SchmolkeM.VargaZ.T.ManicassamyB.WangT.T.BelserJ.A.PearceM.B.Garcia-SastreA.TumpeyT.M.PaleseP.PB1-F2 expression by the 2009 pandemic H1N1" exact="influenza" post="virus has minimal impact on virulence in animal modelsJ."/>
  <result pre="in animal modelsJ. Virol.2010844442445010.1128/JVI.02717-0920181699 16.JaggerB.W.WiseH.M.KashJ.C.WaltersK.A.WillsN.M.XiaoY.L.DunfeeR.L.SchwartzmanL.M.OzinskyA.BellG.L.et al.An overlapping protein-coding region in" exact="influenza" post="A virus segment 3 modulates the host responseScience201233719920410.1126/science.122221322745253 17.ShimizuT.TakizawaN.WatanabeK.NagataK.KobayashiN.Crucial"/>
  <result pre="segment 3 modulates the host responseScience201233719920410.1126/science.122221322745253 17.ShimizuT.TakizawaN.WatanabeK.NagataK.KobayashiN.Crucial role of the" exact="influenza" post="virus NS2 (NEP) C-terminal domain in M1 binding and"/>
  <result pre="and nuclear export of vRNPFEBS Lett.2011585414610.1016/j.febslet.2010.11.01721081124 18.PohlM.O.LanzC.StertzS.Late stages of the" exact="influenza" post="A virus replication cycle—A tight interplay between virus and"/>
  <result pre="and assembly of viral membrane proteinsVirology199319354556210.1006/viro.1993.11648460475 20.GerberM.IselC.MoulesV.MarquetR.Selective packaging of the" exact="influenza" post="A genome and consequences for genetic reassortmentTrends Microbiol.20142244645510.1016/j.tim.2014.04.00124798745 21.RossmanJ.S.LambR.A.Influenza"/>
  <result pre="membrane scissionCell201014290291310.1016/j.cell.2010.08.02920850012 23.ColmanP.M.VargheseJ.N.LaverW.G.Structure of the catalytic and antigenic sites in" exact="influenza" post="virus neuraminidaseNature1983303414410.1038/303041a06188957 24.TisoncikJ.R.GuoY.CorderoK.S.YuJ.WangJ.CaoY.RongL.Identification of critical residues of influenza neuraminidase"/>
  <result pre="sites in influenza virus neuraminidaseNature1983303414410.1038/303041a06188957 24.TisoncikJ.R.GuoY.CorderoK.S.YuJ.WangJ.CaoY.RongL.Identification of critical residues of" exact="influenza" post="neuraminidase in viral particle releaseVirol. J.201181410.1186/1743-422X-8-1421232128 25.ThompsonW.W.ShayD.K.WeintraubE.BrammerL.BridgesC.B.CoxN.J.FukudaK.Influenza-associated hospitalizations in"/>
  <result pre="for why some countries were harder hit by the pandemic" exact="influenza" post="virus in 2009—A global mortality impact modeling studyBMC Infect."/>
  <result pre="impact modeling studyBMC Infect. Dis.20171764210.1186/s12879-017-2730-028946870 29.MolinariN.A.Ortega-SanchezI.R.MessonnierM.L.ThompsonW.W.WortleyP.M.WeintraubE.BridgesC.B.The annual impact of seasonal" exact="influenza" post="in the US: Measuring disease burden and costsVaccine2007255086509610.1016/j.vaccine.2007.03.04617544181 30.DorratoltajN.MaratheA.LewisB.L.SwarupS.EubankS.G.AbbasK.M.Epidemiological"/>
  <result pre="disease burden and costsVaccine2007255086509610.1016/j.vaccine.2007.03.04617544181 30.DorratoltajN.MaratheA.LewisB.L.SwarupS.EubankS.G.AbbasK.M.Epidemiological and economic impact of pandemic" exact="influenza" post="in Chicago: Priorities for vaccine interventionsPLoS Comput. Biol.201713e100552110.1371/journal.pcbi.100552128570660 31.MostafaA.AbdelwhabE.M.MettenleiterT.C.PleschkaS.Zoonotic"/>
  <result pre="VaccinesMMWR Recomm. Rep.20166515410.15585/mmwr.rr6505a127560619 35.HampsonA.BarrI.CoxN.DonisR.O.SiddhivinayakH.JerniganD.KatzJ.McCauleyJ.MottaF.OdagiriT.et al.Improving the selection and development of" exact="influenza" post="vaccine viruses—Report of a WHO informal consultation on improving"/>
  <result pre="influenza vaccine viruses—Report of a WHO informal consultation on improving" exact="influenza" post="vaccine virus selection, Hong Kong SAR, China, 18–20 November"/>
  <result pre="selection and recent studies on the global migration of seasonal" exact="influenza" post="virusesVaccine200826Suppl. 4D31D3410.1016/j.vaccine.2008.07.07819230156 38.BarberisI.MylesP.AultS.K.BragazziN.L.MartiniM.History and evolution of influenza control through"/>
  <result pre="migration of seasonal influenza virusesVaccine200826Suppl. 4D31D3410.1016/j.vaccine.2008.07.07819230156 38.BarberisI.MylesP.AultS.K.BragazziN.L.MartiniM.History and evolution of" exact="influenza" post="control through vaccination: From the first monovalent vaccine to"/>
  <result pre="Influenza Virus in Chick EmbryosJ. Exp. Med.19447917318310.1084/jem.79.2.17319871361 40.WongS.S.WebbyR.J.Traditional and new" exact="influenza" post="vaccinesClin. Microbiol. Rev.20132647649210.1128/CMR.00097-1223824369 41.CoxR.J.BrokstadK.A.OgraP.Influenza virus: Immunity and vaccination strategies."/>
  <result pre="Comparison of the immune response to inactivated and live, attenuated" exact="influenza" post="vaccinesScand. J. Immunol.20045911510.1111/j.0300-9475.2004.01382.x14723616 42.LaverW.G.WebsterR.G.Preparation and immunogenicity of an influenza"/>
  <result pre="attenuated influenza vaccinesScand. J. Immunol.20045911510.1111/j.0300-9475.2004.01382.x14723616 42.LaverW.G.WebsterR.G.Preparation and immunogenicity of an" exact="influenza" post="virus hemagglutinin and neuraminidase subunit vaccineVirology19766951152210.1016/0042-6822(76)90481-51258359 43.CoxM.M.PatriarcaP.A.TreanorJ.FluBlok, a recombinant"/>
  <result pre="virus hemagglutinin and neuraminidase subunit vaccineVirology19766951152210.1016/0042-6822(76)90481-51258359 43.CoxM.M.PatriarcaP.A.TreanorJ.FluBlok, a recombinant hemagglutinin" exact="influenza" post="vaccineInfluenza Other Respir. Viruses2008221121910.1111/j.1750-2659.2008.00053.x19453397 44.BeyerW.E.PalacheA.M.de JongJ.C.OsterhausA.D.Cold-adapted live influenza vaccine"/>
  <result pre="recombinant hemagglutinin influenza vaccineInfluenza Other Respir. Viruses2008221121910.1111/j.1750-2659.2008.00053.x19453397 44.BeyerW.E.PalacheA.M.de JongJ.C.OsterhausA.D.Cold-adapted live" exact="influenza" post="vaccine versus inactivated vaccine: Systemic vaccine reactions, local and"/>
  <result pre="and vaccine efficacy. A meta-analysisVaccine2002201340135310.1016/S0264-410X(01)00471-611818152 45.KatayoseM.HosoyaM.HanedaT.YamaguchiH.KawasakiY.SatoM.WrightP.F.The effectiveness of trivalent inactivated" exact="influenza" post="vaccine in children over six consecutive influenza seasonsVaccine2011291844184910.1016/j.vaccine.2010.12.04921195802 46.LuksicI.ClayS.FalconerR.PulanicD.RudanI.CampbellH.NairH.Effectiveness"/>
  <result pre="of trivalent inactivated influenza vaccine in children over six consecutive" exact="influenza" post="seasonsVaccine2011291844184910.1016/j.vaccine.2010.12.04921195802 46.LuksicI.ClayS.FalconerR.PulanicD.RudanI.CampbellH.NairH.Effectiveness of seasonal influenza vaccines in children—A systematic"/>
  <result pre="in children over six consecutive influenza seasonsVaccine2011291844184910.1016/j.vaccine.2010.12.04921195802 46.LuksicI.ClayS.FalconerR.PulanicD.RudanI.CampbellH.NairH.Effectiveness of seasonal" exact="influenza" post="vaccines in children—A systematic review and meta-analysisCroat Med. J.20135413514510.3325/cmj.2013.54.13523630141"/>
  <result pre="review and meta-analysisCroat Med. J.20135413514510.3325/cmj.2013.54.13523630141 47.CoxR.J.BrokstadK.A.The postvaccination antibody response to" exact="influenza" post="virus proteinsAPMIS199910728929610.1111/j.1699-0463.1999.tb01556.x10223301 48.SalettiG.GerlachT.RimmelzwaanG.F.Influenza vaccines: ‘tailor-made’ or ‘one fits all’Curr."/>
  <result pre="of T cell receptor repertoire in response to subunit inactivated" exact="influenza" post="vaccineVaccine2018361599160510.1016/j.vaccine.2018.02.02729454515 50.HoftD.F.LottenbachK.R.BlazevicA.TuranA.BlevinsT.P.PacatteT.P.YuY.MitchellM.C.HoftS.G.BelsheR.B.Comparisons of the Humoral and Cellular Immune Responses"/>
  <result pre="Immunol.20172410.1128/CVI.00414-16 51.ForrestB.D.PrideM.W.DunningA.J.CapedingM.R.ChotpitayasunondhT.TamJ.S.RappaportR.EldridgeJ.H.GruberW.C.Correlation of cellular immune responses with protection against culture-confirmed" exact="influenza" post="virus in young childrenClin. Vaccine Immunol.2008151042105310.1128/CVI.00397-0718448618 52.HoftD.F.BabusisE.WorkuS.SpencerC.T.LottenbachK.TruscottS.M.AbateG.SakalaI.G.EdwardsK.M.CreechC.B.et al.Live and"/>
  <result pre="virus in young childrenClin. Vaccine Immunol.2008151042105310.1128/CVI.00397-0718448618 52.HoftD.F.BabusisE.WorkuS.SpencerC.T.LottenbachK.TruscottS.M.AbateG.SakalaI.G.EdwardsK.M.CreechC.B.et al.Live and inactivated" exact="influenza" post="vaccines induce similar humoral responses, but only live vaccines"/>
  <result pre="antibody and T-cell responses elicited by licensed inactivated- and live-attenuated" exact="influenza" post="vaccines against H3N2 hemagglutininHum. Immunol.20117246346910.1016/j.humimm.2011.03.00121414368 55.ChengX.ZengelJ.R.SuguitanA.L.Jr.XuQ.WangW.LinJ.JinH.Evaluation of the humoral"/>
  <result pre="cellular immune responses elicited by the live attenuated and inactivated" exact="influenza" post="vaccines and their roles in heterologous protection in ferretsJ."/>
  <result pre="Dis.201320859460210.1093/infdis/jit20723656978 56.JinH.LuB.ZhouH.MaC.ZhaoJ.YangC.F.KembleG.GreenbergH.Multiple amino acid residues confer temperature sensitivity to human" exact="influenza" post="virus vaccine strains (FluMist) derived from cold-adapted A/Ann Arbor/6/60Virology2003306182410.1016/S0042-6822(02)00035-112620793"/>
  <result pre="flu vaccineAm. Soc. Microbiol. News200369426427 58.MaassabH.F.Adaptation and growth characteristics of" exact="influenza" post="virus at 25 degrees CNature196721361261410.1038/213612a06040602 59.CoxN.J.KitameF.KendalA.P.MaassabH.F.NaeveC.Identification of sequence changes"/>
  <result pre="CNature196721361261410.1038/213612a06040602 59.CoxN.J.KitameF.KendalA.P.MaassabH.F.NaeveC.Identification of sequence changes in the cold-adapted, live attenuated" exact="influenza" post="vaccine strain, A/Ann Arbor/6/60 (H2N2)Virology198816755456710.1016/0042-6822(88)90118-32974219 60.MurphyB.R.CoelinghK.Principles underlying the development"/>
  <result pre="60.MurphyB.R.CoelinghK.Principles underlying the development and use of live attenuated cold-adapted" exact="influenza" post="A and B virus vaccinesViral Immunol.20021529532310.1089/0882824026006624212081014 61.CoxA.BakerS.F.NogalesA.Martinez-SobridoL.DewhurstS.Development of a"/>
  <result pre="B virus vaccinesViral Immunol.20021529532310.1089/0882824026006624212081014 61.CoxA.BakerS.F.NogalesA.Martinez-SobridoL.DewhurstS.Development of a mouse-adapted live attenuated" exact="influenza" post="virus that permits in vivo analysis of enhancements to"/>
  <result pre="vivo analysis of enhancements to the safety of live attenuated" exact="influenza" post="virus vaccineJ. Virol.2015893421342610.1128/JVI.02636-1425552727 62.AbramsonJ.S.Intranasal, cold-adapted, live, attenuated influenza vaccinePediatr."/>
  <result pre="live attenuated influenza virus vaccineJ. Virol.2015893421342610.1128/JVI.02636-1425552727 62.AbramsonJ.S.Intranasal, cold-adapted, live, attenuated" exact="influenza" post="vaccinePediatr. Infect. Dis. J.1999181103110410.1097/00006454-199912000-0001710608635 63.JinH.ChenZ.Production of live attenuated influenza"/>
  <result pre="attenuated influenza vaccinePediatr. Infect. Dis. J.1999181103110410.1097/00006454-199912000-0001710608635 63.JinH.ChenZ.Production of live attenuated" exact="influenza" post="vaccines against seasonal and potential pandemic influenza virusesCurr. Opin."/>
  <result pre="of live attenuated influenza vaccines against seasonal and potential pandemic" exact="influenza" post="virusesCurr. Opin. Virol.20146343910.1016/j.coviro.2014.02.00824705137 64.SongJ.H.NguyenH.H.CuburuN.HorimotoT.KoS.Y.ParkS.H.CzerkinskyC.KweonM.N.Sublingual vaccination with influenza virus protects"/>
  <result pre="and potential pandemic influenza virusesCurr. Opin. Virol.20146343910.1016/j.coviro.2014.02.00824705137 64.SongJ.H.NguyenH.H.CuburuN.HorimotoT.KoS.Y.ParkS.H.CzerkinskyC.KweonM.N.Sublingual vaccination with" exact="influenza" post="virus protects mice against lethal viral infectionProc. Natl. Acad."/>
  <result pre="Acad. Sci. USA20081051644164910.1073/pnas.070868410518227512 65.ZielinskiM.R.SouzaG.TaishiP.BohnetS.G.KruegerJ.M.Olfactory bulb and hypothalamic acute-phase responses to" exact="influenza" post="virus: Effects of immunizationNeuroimmunomodulation20132032333310.1159/00035171623948712 66.PronkerE.S.ClaassenE.OsterhausA.D.Development of new generation influenza"/>
  <result pre="to influenza virus: Effects of immunizationNeuroimmunomodulation20132032333310.1159/00035171623948712 66.PronkerE.S.ClaassenE.OsterhausA.D.Development of new generation" exact="influenza" post="vaccines: Recipes for success?Vaccine2012307344734710.1016/j.vaccine.2012.09.07123044407 67.TalbotT.R.CrockerD.D.PetersJ.DoersamJ.K.IkizlerM.R.SannellaE.WrightP.E.EdwardsK.M.Duration of virus shedding after"/>
  <result pre="success?Vaccine2012307344734710.1016/j.vaccine.2012.09.07123044407 67.TalbotT.R.CrockerD.D.PetersJ.DoersamJ.K.IkizlerM.R.SannellaE.WrightP.E.EdwardsK.M.Duration of virus shedding after trivalent intranasal live attenuated" exact="influenza" post="vaccination in adultsInfect. Control Hosp. Epidemiol.20052649450010.1086/50257415954490 68.CarterN.J.CurranM.P.Live attenuated influenza"/>
  <result pre="attenuated influenza vaccination in adultsInfect. Control Hosp. Epidemiol.20052649450010.1086/50257415954490 68.CarterN.J.CurranM.P.Live attenuated" exact="influenza" post="vaccine (FluMist(R); Fluenz): A review of its use in"/>
  <result pre="A review of its use in the prevention of seasonal" exact="influenza" post="in children and adultsDrugs2011711591162210.2165/11206860-000000000-0000021861544 69.RhorerJ.AmbroseC.S.DickinsonS.HamiltonH.OlekaN.A.MalinoskiF.J.WittesJ.Efficacy of live attenuated influenza"/>
  <result pre="seasonal influenza in children and adultsDrugs2011711591162210.2165/11206860-000000000-0000021861544 69.RhorerJ.AmbroseC.S.DickinsonS.HamiltonH.OlekaN.A.MalinoskiF.J.WittesJ.Efficacy of live attenuated" exact="influenza" post="vaccine in children: A meta-analysis of nine randomized clinical"/>
  <result pre="cold-adapted B/Ann Arbor/1/66, the master donor virus for live attenuated" exact="influenza" post="FluMist vaccinesVirology200838035436210.1016/j.virol.2008.08.01018804834 72.FioreA.E.UyekiT.M.BroderK.FinelliL.EulerG.L.SingletonJ.A.IskanderJ.K.WortleyP.M.ShayD.K.BreseeJ.S.et al.Prevention and control of influenza with"/>
  <result pre="live attenuated influenza FluMist vaccinesVirology200838035436210.1016/j.virol.2008.08.01018804834 72.FioreA.E.UyekiT.M.BroderK.FinelliL.EulerG.L.SingletonJ.A.IskanderJ.K.WortleyP.M.ShayD.K.BreseeJ.S.et al.Prevention and control of" exact="influenza" post="with vaccines: Recommendations of the Advisory Committee on Immunization"/>
  <result pre="Vaccine EffectivenessVaccines201862810.3390/vaccines602002829883414 75.ManzoliL.IoannidisJ.P.FlaccoM.E.De VitoC.VillariP.Effectiveness and harms of seasonal and pandemic" exact="influenza" post="vaccines in children, adults and elderly: A critical review"/>
  <result pre="15 meta-analysesHum. Vaccines Immunother.2012885186210.4161/hv.1991722777099 76.WilsonI.A.CoxN.J.Structural basis of immune recognition of" exact="influenza" post="virus hemagglutininAnnu. Rev. Immunol.1990873777110.1146/annurev.iy.08.040190.0035132188678 77.SinganayagamA.ZambonM.LalvaniA.BarclayW.Urgent challenges in implementing live"/>
  <result pre="virus hemagglutininAnnu. Rev. Immunol.1990873777110.1146/annurev.iy.08.040190.0035132188678 77.SinganayagamA.ZambonM.LalvaniA.BarclayW.Urgent challenges in implementing live attenuated" exact="influenza" post="vaccineLancet Infect. Dis.201818e25e3210.1016/S1473-3099(17)30360-228780285 78.OsterholmM.T.KelleyN.S.SommerA.BelongiaE.A.Efficacy and effectiveness of influenza vaccines:"/>
  <result pre="live attenuated influenza vaccineLancet Infect. Dis.201818e25e3210.1016/S1473-3099(17)30360-228780285 78.OsterholmM.T.KelleyN.S.SommerA.BelongiaE.A.Efficacy and effectiveness of" exact="influenza" post="vaccines: A systematic review and meta-analysisLancet Infect. Dis.201212364410.1016/S1473-3099(11)70295-X22032844 79.AmbroseC.S.LevinM.J.BelsheR.B.The"/>
  <result pre="Dis.201212364410.1016/S1473-3099(11)70295-X22032844 79.AmbroseC.S.LevinM.J.BelsheR.B.The relative efficacy of trivalent live attenuated and inactivated" exact="influenza" post="vaccines in children and adultsInfluenza Other. Respir. Viruses20115677510.1111/j.1750-2659.2010.00183.x21306569 80.JeffersonT.RivettiA.Di"/>
  <result pre="children and adultsInfluenza Other. Respir. Viruses20115677510.1111/j.1750-2659.2010.00183.x21306569 80.JeffersonT.RivettiA.Di PietrantonjC.DemicheliV.FerroniE.Vaccines for preventing" exact="influenza" post="in healthy childrenCochrane Database Syst. Rev.2008CD00487910.1002/14651858.CD004879.pub418425905 81.ChungJ.R.FlanneryB.ThompsonM.G.GaglaniM.JacksonM.L.MontoA.S.NowalkM.P.TalbotH.K.TreanorJ.J.BelongiaE.A.et al.Seasonal Effectiveness"/>
  <result pre="Live Attenuated and Inactivated Influenza VaccinePediatrics2016137e2015327910.1542/peds.2015-327926738884 82.McLeanH.Q.CaspardH.GriffinM.R.PoehlingK.A.GaglaniM.BelongiaE.A.TalbotH.K.PetersT.R.MurthyK.AmbroseC.S.Effectiveness of live attenuated" exact="influenza" post="vaccine and inactivated influenza vaccine in children during the"/>
  <result pre="Influenza VaccinePediatrics2016137e2015327910.1542/peds.2015-327926738884 82.McLeanH.Q.CaspardH.GriffinM.R.PoehlingK.A.GaglaniM.BelongiaE.A.TalbotH.K.PetersT.R.MurthyK.AmbroseC.S.Effectiveness of live attenuated influenza vaccine and inactivated" exact="influenza" post="vaccine in children during the 2014–2015 seasonVaccine2017352685269310.1016/j.vaccine.2017.03.08528408121 83.PoehlingK.A.CaspardH.PetersT.R.BelongiaE.A.CongeniB.GaglaniM.GriffinM.R.IrvingS.A.KavathekarP.K.McLeanH.Q.et al.2015-2016"/>
  <result pre="States, 2018–19 Influenza SeasonMMWR Morb. Mortal. Wkly. Rep.20186764364510.15585/mmwr.mm6722a529879095 88.PebodyR.McMenaminJ.NohynekH.Live attenuated" exact="influenza" post="vaccine (LAIV): Recent effectiveness results from the USA and"/>
  <result pre="the editor: Potential causes of the decreased effectiveness of the" exact="influenza" post="A(H1N1)pdm09 strain in live attenuated influenza vaccinesEurosurveill2016213039410.2807/1560-7917.ES.2016.21.45.30394 90.SridharS.BegomS.BerminghamA.HoschlerK.AdamsonW.CarmanW.BeanT.BarclayW.DeeksJ.J.LalvaniA.Cellular immune"/>
  <result pre="decreased effectiveness of the influenza A(H1N1)pdm09 strain in live attenuated" exact="influenza" post="vaccinesEurosurveill2016213039410.2807/1560-7917.ES.2016.21.45.30394 90.SridharS.BegomS.BerminghamA.HoschlerK.AdamsonW.CarmanW.BeanT.BarclayW.DeeksJ.J.LalvaniA.Cellular immune correlates of protection against symptomatic pandemic"/>
  <result pre="Med.2013191305131210.1038/nm.335024056771 91.ElderfieldR.A.WatsonS.J.GodleeA.AdamsonW.E.ThompsonC.I.DunningJ.Fernandez-AlonsoM.BlumenkrantzD.HussellT.InvestigatorsM.et al.Accumulation of human-adapting mutations during circulation of A(H1N1)pdm09" exact="influenza" post="virus in humans in the United KingdomJ. Virol.201488132691328310.1128/JVI.01636-1425210166 92.RussierM.YangG.RehgJ.E.WongS.S.MostafaH.H.FabrizioT.P.BarmanS.KraussS.WebsterR.G.WebbyR.J.et"/>
  <result pre="the United KingdomJ. Virol.201488132691328310.1128/JVI.01636-1425210166 92.RussierM.YangG.RehgJ.E.WongS.S.MostafaH.H.FabrizioT.P.BarmanS.KraussS.WebsterR.G.WebbyR.J.et al.Molecular requirements for a pandemic" exact="influenza" post="virus: An acid-stable hemagglutinin proteinProc. Natl. Acad. Sci. USA20161131636164110.1073/pnas.152438411326811446"/>
  <result pre="and thermal stability of the hemagglutinin of pandemic live attenuated" exact="influenza" post="virus vaccinesJ. Virol.201488123741238410.1128/JVI.01107-1425122789 94.LaurieK.L.GuarnacciaT.A.CarolanL.A.YanA.W.AbanM.PetrieS.CaoP.HeffernanJ.M.McVernonJ.MosseJ.et al.Interval Between Infections and Viral"/>
  <result pre="95.CaspardH.CoelinghK.L.MalloryR.M.AmbroseC.S.Association of vaccine handling conditions with effectiveness of live attenuated" exact="influenza" post="vaccine against H1N1pdm09 viruses in the United StatesVaccine2016345066507210.1016/j.vaccine.2016.08.07927613072 96.GouldP.S.EastonA.J.DimmockN.J.Live"/>
  <result pre="Virol.20179110.1128/JVI.02211-1627928017 100.FriedeM.PalkonyayL.AlfonsoC.PervikovY.TorelliG.WoodD.KienyM.P.WHO initiative to increase global and equitable access to" exact="influenza" post="vaccine in the event of a pandemic: Supporting developing"/>
  <result pre="production capacity through technology transferVaccine201129Suppl. 1A2A710.1016/j.vaccine.2011.02.07921684422 101.BurgessT.H.MurrayC.K.BavaroM.F.LandrumM.L.O’BryanT.A.RosasJ.G.CammarataS.M.MartinN.J.EwingD.RaviprakashK.et al.Self-administration of intranasal" exact="influenza" post="vaccine: Immunogenicity and volunteer acceptanceVaccine2015333894389910.1016/j.vaccine.2015.06.06126117150 102.BakerS.F.NogalesA.FinchC.TuffyK.M.DommW.PerezD.R.TophamD.J.Martinez-SobridoL.Influenza A and B"/>
  <result pre="reassortment through compatible viral packaging signalsJ. Virol.201488107781079110.1128/JVI.01440-1425008914 103.JacksonD.ElderfieldR.A.BarclayW.S.Molecular studies of" exact="influenza" post="B virus in the reverse genetics eraJ. Gen. Virol.20119211710.1099/vir.0.026187-020926635"/>
  <result pre="in the reverse genetics eraJ. Gen. Virol.20119211710.1099/vir.0.026187-020926635 104.Martinez-SobridoL.Garcia-SastreA.Generation of recombinant" exact="influenza" post="virus from plasmid DNAJ. Vis. Exp.201010.3791/205720729804 105.EngelhardtO.G.Many ways to"/>
  <result pre="from plasmid DNAJ. Vis. Exp.201010.3791/205720729804 105.EngelhardtO.G.Many ways to make an" exact="influenza" post="virus—Review of influenza virus reverse genetics methodsInfluenza Other. Respir."/>
  <result pre="Vis. Exp.201010.3791/205720729804 105.EngelhardtO.G.Many ways to make an influenza virus—Review of" exact="influenza" post="virus reverse genetics methodsInfluenza Other. Respir. Viruses2013724925610.1111/j.1750-2659.2012.00392.x22712782 106.Martinez-SobridoL.CadaganR.SteelJ.BaslerC.F.PaleseP.MoranT.M.Garcia-SastreA.Hemagglutinin-pseudotyped green"/>
  <result pre="reverse genetics methodsInfluenza Other. Respir. Viruses2013724925610.1111/j.1750-2659.2012.00392.x22712782 106.Martinez-SobridoL.CadaganR.SteelJ.BaslerC.F.PaleseP.MoranT.M.Garcia-SastreA.Hemagglutinin-pseudotyped green fluorescent protein-expressing" exact="influenza" post="viruses for the detection of influenza virus neutralizing antibodiesJ."/>
  <result pre="106.Martinez-SobridoL.CadaganR.SteelJ.BaslerC.F.PaleseP.MoranT.M.Garcia-SastreA.Hemagglutinin-pseudotyped green fluorescent protein-expressing influenza viruses for the detection of" exact="influenza" post="virus neutralizing antibodiesJ. Virol.2010842157216310.1128/JVI.01433-0919939917 107.NogalesA.BakerS.F.DommW.Martinez-SobridoL.Development and applications of single-cycle"/>
  <result pre="virus neutralizing antibodiesJ. Virol.2010842157216310.1128/JVI.01433-0919939917 107.NogalesA.BakerS.F.DommW.Martinez-SobridoL.Development and applications of single-cycle infectious" exact="influenza" post="A virus (sciIAV)Virus Res.2016216264010.1016/j.virusres.2015.07.01326220478 108.NogalesA.BakerS.F.Martinez-SobridoL.Replication-competent influenza A viruses expressing"/>
  <result pre="applications of single-cycle infectious influenza A virus (sciIAV)Virus Res.2016216264010.1016/j.virusres.2015.07.01326220478 108.NogalesA.BakerS.F.Martinez-SobridoL.Replication-competent" exact="influenza" post="A viruses expressing a red fluorescent proteinVirology201547620621610.1016/j.virol.2014.12.00625553516 109.BreenM.NogalesA.BakerS.F.Martinez-SobridoL.Replication-Competent Influenza"/>
  <result pre="In Vitro and In Vivo StudiesPLoS ONE201611e014772310.1371/journal.pone.014772326809059 111.RodriguezL.NogalesA.MurciaP.R.ParrishC.R.Martinez-SobridoL.A bivalent live-attenuated" exact="influenza" post="vaccine for the control and prevention of H3N8 and"/>
  <result pre="for the control and prevention of H3N8 and H3N2 canine" exact="influenza" post="virusesVaccine2017354374438110.1016/j.vaccine.2017.06.06028709557 112.RodriguezL.NogalesA.ReillyE.C.TophamD.J.MurciaP.R.ParrishC.R.Martinez SobridoL.A live-attenuated influenza vaccine for H3N2 canine"/>
  <result pre="of H3N8 and H3N2 canine influenza virusesVaccine2017354374438110.1016/j.vaccine.2017.06.06028709557 112.RodriguezL.NogalesA.ReillyE.C.TophamD.J.MurciaP.R.ParrishC.R.Martinez SobridoL.A live-attenuated" exact="influenza" post="vaccine for H3N2 canine influenza virusVirology20175049610610.1016/j.virol.2017.01.02028167384 113.RodriguezL.ReedyS.NogalesA.MurciaP.R.ChambersT.M.Martinez-SobridoL.Development of a"/>
  <result pre="influenza virusesVaccine2017354374438110.1016/j.vaccine.2017.06.06028709557 112.RodriguezL.NogalesA.ReillyE.C.TophamD.J.MurciaP.R.ParrishC.R.Martinez SobridoL.A live-attenuated influenza vaccine for H3N2 canine" exact="influenza" post="virusVirology20175049610610.1016/j.virol.2017.01.02028167384 113.RodriguezL.ReedyS.NogalesA.MurciaP.R.ChambersT.M.Martinez-SobridoL.Development of a novel equine influenza virus live-attenuated"/>
  <result pre="for H3N2 canine influenza virusVirology20175049610610.1016/j.virol.2017.01.02028167384 113.RodriguezL.ReedyS.NogalesA.MurciaP.R.ChambersT.M.Martinez-SobridoL.Development of a novel equine" exact="influenza" post="virus live-attenuated vaccineVirology2018516768510.1016/j.virol.2018.01.00529331866 114.NogalesA.Martinez-SobridoL.Reverse Genetics Approaches for the Development"/>
  <result pre="J. Mol. Sci.2016182010.3390/ijms1801002028025504 115.HoffmannE.NeumannG.KawaokaY.HobomG.WebsterR.G.A DNA transfection system for generation of" exact="influenza" post="A virus from eight plasmidsProc. Natl. Acad. Sci. USA2000976108611310.1073/pnas.10013369710801978"/>
  <result pre="Natl. Acad. Sci. USA2000976108611310.1073/pnas.10013369710801978 116.HoffmannE.NeumannG.HobomG.WebsterR.G.KawaokaY.&quot;Ambisense�? approach for the generation of" exact="influenza" post="A virus: vRNA and mRNA synthesis from one templateVirology200026731031710.1006/viro.1999.014010662626"/>
  <result pre="Viruses by Reverse GeneticsWHOGeneva, Switzerland2005 118.PerdueM.L.ArnoldF.LiS.DonabedianA.CioceV.WarfT.HuebnerR.The future of cell culture-based" exact="influenza" post="vaccine productionExpert Rev. Vaccines2011101183119410.1586/erv.11.8221854311 119.HegdeN.R.Cell culture-based influenza vaccines: A"/>
  <result pre="of cell culture-based influenza vaccine productionExpert Rev. Vaccines2011101183119410.1586/erv.11.8221854311 119.HegdeN.R.Cell culture-based" exact="influenza" post="vaccines: A necessary and indispensable investment for the futureHum."/>
  <result pre="Methods2013193284110.1016/j.jviromet.2013.04.02023684847 123.HardingA.T.HeatonN.S.Efforts to Improve the Seasonal Influenza VaccineVaccines201861910.3390/vaccines6020019 124.BarrI.G.DonisR.O.KatzJ.M.McCauleyJ.W.OdagiriT.TrusheimH.TsaiT.F.WentworthD.E.Cell culture-derived" exact="influenza" post="vaccines in the severe 2017–2018 epidemic season: A step"/>
  <result pre="in the severe 2017–2018 epidemic season: A step towards improved" exact="influenza" post="vaccine effectivenessNPJ Vaccines201834410.1038/s41541-018-0079-z30323955 125.FulviniA.A.RamanunninairM.LeJ.PokornyB.A.ArroyoJ.M.SilvermanJ.DevisR.BucherD.Gene constellation of influenza A virus"/>
  <result pre="step towards improved influenza vaccine effectivenessNPJ Vaccines201834410.1038/s41541-018-0079-z30323955 125.FulviniA.A.RamanunninairM.LeJ.PokornyB.A.ArroyoJ.M.SilvermanJ.DevisR.BucherD.Gene constellation of" exact="influenza" post="A virus reassortants with high growth phenotype prepared as"/>
  <result pre="seed candidates for vaccine productionPLoS ONE20116e2082310.1371/journal.pone.002082321695145 126.Del GiudiceG.RappuoliR.Inactivated and adjuvanted" exact="influenza" post="vaccinesCurr. Top. Microbiol. Immunol.201538615118010.1007/82_2014_40625038938 127.NicolsonC.MajorD.WoodJ.M.RobertsonJ.S.Generation of influenza vaccine viruses"/>
  <result pre="GiudiceG.RappuoliR.Inactivated and adjuvanted influenza vaccinesCurr. Top. Microbiol. Immunol.201538615118010.1007/82_2014_40625038938 127.NicolsonC.MajorD.WoodJ.M.RobertsonJ.S.Generation of" exact="influenza" post="vaccine viruses on Vero cells by reverse genetics: An"/>
  <result pre="for delayed selection intensifyNat. Med.20152129729810.1038/nm0415-29725849262 130.HaleB.G.RandallR.E.OrtinJ.JacksonD.The multifunctional NS1 protein of" exact="influenza" post="A virusesJ. Gen. Virol.2008892359237610.1099/vir.0.2008/004606-018796704 131.TisoncikJ.R.BillharzR.BurmakinaS.BelisleS.E.ProllS.C.KorthM.J.Garcia-SastreA.KatzeM.G.The NS1 protein of influenza"/>
  <result pre="of influenza A virusesJ. Gen. Virol.2008892359237610.1099/vir.0.2008/004606-018796704 131.TisoncikJ.R.BillharzR.BurmakinaS.BelisleS.E.ProllS.C.KorthM.J.Garcia-SastreA.KatzeM.G.The NS1 protein of" exact="influenza" post="A virus suppresses interferon-regulated activation of antigen-presentation and immune-proteasome"/>
  <result pre="Restores Its Ability to Inhibit Host Gene ExpressionJ. Virol.20179110.1128/JVI.00877-1728835506 138.NogalesA.HuangK.ChaucheC.DeDiegoM.L.MurciaP.R.ParrishC.R.Martinez-SobridoL.Canine" exact="influenza" post="viruses with modified NS1 proteins for the development of"/>
  <result pre="in interferon-deficient systemsVirology199825232433010.1006/viro.1998.95089878611 143.FalconA.M.Fernandez-SesmaA.NakayaY.MoranT.M.OrtinJ.Garcia-SastreA.Attenuation and immunogenicity in mice of temperature-sensitive" exact="influenza" post="viruses expressing truncated NS1 proteinsJ. Gen. Virol.2005862817282110.1099/vir.0.80991-016186237 144.ChenC.FanW.LiJ.ZhengW.ZhangS.YangL.LiuD.LiuW.SunL.A Promising"/>
  <result pre="Influenza Vaccine VirusFront. Cell. Infect. Microbiol.2018812710.3389/fcimb.2018.0012729765910 145.LambR.A.ChoppinP.W.Segment 8 of the" exact="influenza" post="virus genome is unique in coding for two polypeptidesProc."/>
  <result pre="for two polypeptidesProc. Natl. Acad. Sci. USA1979764908491210.1073/pnas.76.10.4908291907 146.QuinlivanM.ZamarinD.Garcia-SastreA.CullinaneA.ChambersT.PaleseP.Attenuation of equine" exact="influenza" post="viruses through truncations of the NS1 proteinJ. Virol.2005798431843910.1128/JVI.79.13.8431-8439.200515956587 147.RichtJ.A.LekcharoensukP.LagerK.M.VincentA.L.LoiaconoC.M.JankeB.H.WuW.H.YoonK.J.WebbyR.J.SolorzanoA.et"/>
  <result pre="the NS1 proteinJ. Virol.2005798431843910.1128/JVI.79.13.8431-8439.200515956587 147.RichtJ.A.LekcharoensukP.LagerK.M.VincentA.L.LoiaconoC.M.JankeB.H.WuW.H.YoonK.J.WebbyR.J.SolorzanoA.et al.Vaccination of pigs against swine" exact="influenza" post="viruses by using an NS1-truncated modified live-virus vaccineJ. Virol.200680110091101810.1128/JVI.00787-0616943300"/>
  <result pre="live-virus vaccineJ. Virol.200680110091101810.1128/JVI.00787-0616943300 148.SolorzanoA.WebbyR.J.LagerK.M.JankeB.H.Garcia-SastreA.RichtJ.A.Mutations in the NS1 protein of swine" exact="influenza" post="virus impair anti-interferon activity and confer attenuation in pigsJ."/>
  <result pre="149.VincentA.L.MaW.LagerK.M.JankeB.H.WebbyR.J.Garcia-SastreA.RichtJ.A.Efficacy of intranasal administration of a truncated NS1 modified live" exact="influenza" post="virus vaccine in swineVaccine2007257999800910.1016/j.vaccine.2007.09.01917933442 150.KappesM.A.SandbulteM.R.PlattR.WangC.LagerK.M.HenningsonJ.N.LorussoA.VincentA.L.LovingC.L.RothJ.A.et al.Vaccination with NS1-truncated H3N2"/>
  <result pre="virus vaccine in swineVaccine2007257999800910.1016/j.vaccine.2007.09.01917933442 150.KappesM.A.SandbulteM.R.PlattR.WangC.LagerK.M.HenningsonJ.N.LorussoA.VincentA.L.LovingC.L.RothJ.A.et al.Vaccination with NS1-truncated H3N2 swine" exact="influenza" post="virus primes T cells and confers cross-protection against an"/>
  <result pre="cross-protection against an H1N1 heterosubtypic challenge in pigsVaccine20123028028810.1016/j.vaccine.2011.10.09822067263 151.SteelJ.LowenA.C.PenaL.AngelM.SolorzanoA.AlbrechtR.PerezD.R.Garcia-SastreA.PaleseP.Live attenuated" exact="influenza" post="viruses containing NS1 truncations as vaccine candidates against H5N1"/>
  <result pre="candidates against H5N1 highly pathogenic avian influenzaJ. Virol.2009831742175310.1128/JVI.01920-0819073731 152.WangL.SuarezD.L.Pantin-JackwoodM.MibayashiM.Garcia-SastreA.SaifY.M.LeeC.W.Characterization of" exact="influenza" post="virus variants with different sizes of the non-structural (NS)"/>
  <result pre="the non-structural (NS) genes and their potential as a live" exact="influenza" post="vaccine in poultryVaccine2008263580358610.1016/j.vaccine.2008.05.00118539366 153.ChoiE.H.SongM.S.ParkS.J.PascuaP.N.BaekY.H.KwonH.I.KimE.H.KimS.JangH.K.PooH.et al.Development of a dual-protective live"/>
  <result pre="of a dual-protective live attenuated vaccine against H5N1 and H9N2" exact="avian influenza" post="viruses by modifying the NS1 geneArch. Virol.20151601729174010.1007/s00705-015-2442-y25959557 154.JangH.NgunjiriJ.M.LeeC.W.Association between"/>
  <result pre="a dual-protective live attenuated vaccine against H5N1 and H9N2 avian" exact="influenza" post="viruses by modifying the NS1 geneArch. Virol.20151601729174010.1007/s00705-015-2442-y25959557 154.JangH.NgunjiriJ.M.LeeC.W.Association between"/>
  <result pre="in ChickensPLoS ONE201611e015660310.1371/journal.pone.015660327257989 155.JangH.ElaishM.KcM.AbundoM.C.GhorbaniA.NgunjiriJ.M.LeeC.W.Efficacy and synergy of live-attenuated and inactivated" exact="influenza" post="vaccines in young chickensPLoS ONE201813e019528510.1371/journal.pone.019528529624615 156.BaskinC.R.Bielefeldt-OhmannH.Garcia-SastreA.TumpeyT.M.Van HoevenN.CarterV.S.ThomasM.J.ProllS.SolorzanoA.BillharzR.et al.Functional genomic"/>
  <result pre="immune response resulting from vaccination of macaques with an NS1-truncated" exact="influenza" post="virusJ. Virol.200781118171182710.1128/JVI.00590-0717715226 157.PicaN.LangloisR.A.KrammerF.MargineI.PaleseP.NS1-truncated live attenuated virus vaccine provides robust"/>
  <result pre="mice from viral challengeJ. Virol.201286102931030110.1128/JVI.01131-1222787224 158.WacheckV.EgorovA.GroissF.PfeifferA.FuerederT.HoeflmayerD.KundiM.Popow-KrauppT.Redlberger-FritzM.MuellerC.A.et al.A novel type of" exact="influenza" post="vaccine: Safety and immunogenicity of replication-deficient influenza virus created"/>
  <result pre="novel type of influenza vaccine: Safety and immunogenicity of replication-deficient" exact="influenza" post="virus created by deletion of the interferon antagonist NS1J."/>
  <result pre="Acad. Sci. USA2000974309431410.1073/pnas.07052599710725408 160.MosslerC.GroissF.WolztM.WolschekM.SeipeltJ.MusterT.Phase I/II trial of a replication-deficient trivalent" exact="influenza" post="virus vaccine lacking NS1Vaccine2013316194620010.1016/j.vaccine.2013.10.06124183981 161.WangX.BaslerC.F.WilliamsB.R.SilvermanR.H.PaleseP.Garcia-SastreA.Functional replacement of the carboxy-terminal"/>
  <result pre="lacking NS1Vaccine2013316194620010.1016/j.vaccine.2013.10.06124183981 161.WangX.BaslerC.F.WilliamsB.R.SilvermanR.H.PaleseP.Garcia-SastreA.Functional replacement of the carboxy-terminal two-thirds of the" exact="influenza" post="A virus NS1 protein with short heterologous dimerization domainsJ."/>
  <result pre="Influenza VirusesPLoS ONE201611e015437610.1371/journal.pone.015437627119730 168.WongE.H.SmithD.K.RabadanR.PeirisM.PoonL.L.Codon usage bias and the evolution of" exact="influenza" post="A viruses. Codon Usage Biases of Influenza VirusBMC Evol."/>
  <result pre="viruses. Codon Usage Biases of Influenza VirusBMC Evol. Biol.20101025310.1186/1471-2148-10-25320723216 169.GoniN.IriarteA.ComasV.SonoraM.MorenoP.MoratorioG.MustoH.CristinaJ.Pandemic" exact="influenza" post="A virus codon usage revisited: Biases, adaptation and implications"/>
  <result pre="171.ZhouT.GuW.MaJ.SunX.LuZ.Analysis of synonymous codon usage in H5N1 virus and other" exact="influenza" post="A virusesBiosystems200581778610.1016/j.biosystems.2005.03.00215917130 172.JenkinsG.M.HolmesE.C.The extent of codon usage bias in"/>
  <result pre="human RNA viruses and its evolutionary originVirus Res.2003921710.1016/S0168-1702(02)00309-X12606071 173.MuellerS.ColemanJ.R.PapamichailD.WardC.B.NimnualA.FutcherB.SkienaS.WimmerE.Live attenuated" exact="influenza" post="virus vaccines by computer-aided rational designNat. Biotechnol.20102872372610.1038/nbt.163620543832 174.YangC.SkienaS.FutcherB.MuellerS.WimmerE.Deliberate reduction"/>
  <result pre="designNat. Biotechnol.20102872372610.1038/nbt.163620543832 174.YangC.SkienaS.FutcherB.MuellerS.WimmerE.Deliberate reduction of hemagglutinin and neuraminidase expression of" exact="influenza" post="virus leads to an ultraprotective live vaccine in miceProc."/>
  <result pre="expression: Codon usage bias manipulation for the generation of novel" exact="influenza" post="A virus vaccinesFuture Virol.20151071573010.2217/fvl.15.3126213563 176.FanR.L.ValkenburgS.A.WongC.K.LiO.T.NichollsJ.M.RabadanR.PeirisJ.S.PoonL.L.Generation of Live Attenuated Influenza"/>
  <result pre="generated by codon-pair bias de-optimization of the 2009 pandemic H1N1" exact="influenza" post="virus, in ferretsVaccine20163456357010.1016/j.vaccine.2015.11.05426655630 178.NogalesA.BakerS.F.Ortiz-RianoE.DewhurstS.TophamD.J.Martinez-SobridoL.Influenza A virus attenuation by codon"/>
  <result pre="pathways occurs in lung epithelial cells infected with low pathogenic" exact="avian influenza" post="virusesPLoS ONE20127e3373210.1371/journal.pone.003373222470468 182.ColemanJ.R.PapamichailD.SkienaS.FutcherB.WimmerE.MuellerS.Virus attenuation by genome-scale changes in codon"/>
  <result pre="occurs in lung epithelial cells infected with low pathogenic avian" exact="influenza" post="virusesPLoS ONE20127e3373210.1371/journal.pone.003373222470468 182.ColemanJ.R.PapamichailD.SkienaS.FutcherB.WimmerE.MuellerS.Virus attenuation by genome-scale changes in codon"/>
  <result pre="Dis.20141448010.1186/1471-2334-14-48025186370 185.ParvinR.BegumJ.A.NooruzzamanM.ChowdhuryE.H.IslamM.R.VahlenkampT.W.Review analysis and impact of co-circulating H5N1 and H9N2" exact="avian influenza" post="viruses in BangladeshEpidemiol. Infect.20181461259126610.1017/S095026881800129229781424 186.PenaL.SuttonT.ChockalingamA.KumarS.AngelM.ShaoH.ChenH.LiW.PerezD.R.Influenza viruses with rearranged genomes"/>
  <result pre="185.ParvinR.BegumJ.A.NooruzzamanM.ChowdhuryE.H.IslamM.R.VahlenkampT.W.Review analysis and impact of co-circulating H5N1 and H9N2 avian" exact="influenza" post="viruses in BangladeshEpidemiol. Infect.20181461259126610.1017/S095026881800129229781424 186.PenaL.SuttonT.ChockalingamA.KumarS.AngelM.ShaoH.ChenH.LiW.PerezD.R.Influenza viruses with rearranged genomes"/>
  <result pre="That Are Antigenically Stable during Growth in EggsMBio2017810.1128/mBio.00669-1728588131 188.LuB.ZhouH.YeD.KembleG.JinH.Improvement of" exact="influenza" post="A/Fujian/411/02 (H3N2) virus growth in embryonated chicken eggs by"/>
  <result pre="human cellsBiotechnol. J.2013881182110.1002/biot.20120036423450727 193.ShihF.F.CerasoliD.M.CatonA.J.A major T cell determinant from the" exact="influenza" post="virus hemagglutinin (HA) can be a cryptic self peptide"/>
  <result pre="transgenic miceInt. Immunol.1997924926110.1093/intimm/9.2.2499040007 194.InagakiA.GotoH.KakugawaS.OzawaM.KawaokaY.Competitive incorporation of homologous gene segments of" exact="influenza" post="A virus into virionsJ. Virol.201286102001020210.1128/JVI.01204-1222740412 195.MarshG.A.HatamiR.PaleseP.Specific residues of the"/>
  <result pre="influenza A virus into virionsJ. Virol.201286102001020210.1128/JVI.01204-1222740412 195.MarshG.A.HatamiR.PaleseP.Specific residues of the" exact="influenza" post="A virus hemagglutinin viral RNA are important for efficient"/>
  <result pre="important for efficient packaging into budding virionsJ. Virol.2007819727973610.1128/JVI.01144-0717634232 196.OzawaM.VictorS.T.TaftA.S.YamadaS.LiC.HattaM.DasS.C.TakashitaE.KakugawaS.MaherE.A.et al.Replication-incompetent" exact="influenza" post="A viruses that stably express a foreign geneJ. Gen."/>
  <result pre="Gen. Virol.2011922879288810.1099/vir.0.037648-021880840 197.BottiniA.DeS.K.BaatenB.J.WuB.BarileE.SoonthornvacharinS.StebbinsJ.L.BradleyL.M.ChandaS.K.PellecchiaM.Identification of small molecules that interfere with H1N1" exact="influenza" post="A viral replicationChemMedChem201272227223510.1002/cmdc.20120045323139022 198.BloomJ.D.GongL.I.BaltimoreD.Permissive secondary mutations enable the evolution"/>
  <result pre="A viral replicationChemMedChem201272227223510.1002/cmdc.20120045323139022 198.BloomJ.D.GongL.I.BaltimoreD.Permissive secondary mutations enable the evolution of" exact="influenza" post="oseltamivir resistanceScience20103281272127510.1126/science.118781620522774 199.BloomJ.D.NayakJ.S.BaltimoreD.A computational-experimental approach identifies mutations that enhance"/>
  <result pre="approach identifies mutations that enhance surface expression of an oseltamivir-resistant" exact="influenza" post="neuraminidasePLoS ONE20116e2220110.1371/journal.pone.002220121799795 200.HooperK.A.CroweJ.E.Jr.BloomJ.D.Influenza viruses with receptor-binding N1 neuraminidases occur"/>
  <result pre="attenuation in cell culture or miceJ. Virol.2015893737374510.1128/JVI.00012-1525609803 201.VictorS.T.WatanabeS.KatsuraH.OzawaM.KawaokaY.A replication-incompetent PB2-knockout" exact="influenza" post="A virus vaccine vectorJ. Virol.2012864123412810.1128/JVI.06232-1122301144 202.UrakiR.KisoM.Iwatsuki-HorimotoK.FukuyamaS.TakashitaE.OzawaM.KawaokaY.A novel bivalent vaccine"/>
  <result pre="vectorJ. Virol.2012864123412810.1128/JVI.06232-1122301144 202.UrakiR.KisoM.Iwatsuki-HorimotoK.FukuyamaS.TakashitaE.OzawaM.KawaokaY.A novel bivalent vaccine based on a PB2-knockout" exact="influenza" post="virus protects mice from pandemic H1N1 and highly pathogenic"/>
  <result pre="H1N1 and highly pathogenic H5N1 virus challengesJ. Virol.2013877874788110.1128/JVI.00076-1323658445 203.KobayashiH.Iwatsuki-HorimotoK.KisoM.UrakiR.IchikoY.TakimotoT.KawaokaY.A replication-incompetent" exact="influenza" post="virus bearing the HN glycoprotein of human parainfluenza virus"/>
  <result pre="of human parainfluenza virus as a bivalent vaccineVaccine2013316239624610.1016/j.vaccine.2013.10.02924144478 204.FonsecaW.OzawaM.HattaM.OrozcoE.MartinezM.B.KawaokaY.A recombinant" exact="influenza" post="virus vaccine expressing the F protein of respiratory syncytial"/>
  <result pre="F protein of respiratory syncytial virusArch. Virol.20141591067107710.1007/s00705-013-1932-z24292020 205.BakerS.F.GuoH.AlbrechtR.A.Garcia-SastreA.TophamD.J.Martinez-SobridoL.Protection against lethal" exact="influenza" post="with a viral mimicJ. Virol.2013878591860510.1128/JVI.01081-1323720727 206.GuoH.BakerS.F.Martinez-SobridoL.TophamD.J.Induction of CD8 T"/>
  <result pre="cell heterologous protection by a single dose of single-cycle infectious" exact="influenza" post="virusJ. Virol.201488120061201610.1128/JVI.01847-1425100831 207.PowellT.J.SilkJ.D.SharpsJ.FodorE.TownsendA.R.Pseudotyped influenza A virus as a vaccine"/>
  <result pre="a single dose of single-cycle infectious influenza virusJ. Virol.201488120061201610.1128/JVI.01847-1425100831 207.PowellT.J.SilkJ.D.SharpsJ.FodorE.TownsendA.R.Pseudotyped" exact="influenza" post="A virus as a vaccine for the induction of"/>
  <result pre="Virol.201286133971340610.1128/JVI.01820-1223015719 208.KatsuraH.Iwatsuki-HorimotoK.FukuyamaS.WatanabeS.SakabeS.HattaY.MurakamiS.ShimojimaM.HorimotoT.KawaokaY.A replication-incompetent virus possessing an uncleavable hemagglutinin as an" exact="influenza" post="vaccineVaccine2012306027603310.1016/j.vaccine.2012.07.05922867723 209.KatsuraH.PiaoZ.Iwatsuki-HorimotoK.AkedaY.WatanabeS.HorimotoT.OishiK.KawaokaY.A bivalent vaccine based on a replication-incompetent influenza"/>
  <result pre="an influenza vaccineVaccine2012306027603310.1016/j.vaccine.2012.07.05922867723 209.KatsuraH.PiaoZ.Iwatsuki-HorimotoK.AkedaY.WatanabeS.HorimotoT.OishiK.KawaokaY.A bivalent vaccine based on a replication-incompetent" exact="influenza" post="virus protects against Streptococcus pneumoniae and influenza virus infectionJ."/>
  <result pre="on a replication-incompetent influenza virus protects against Streptococcus pneumoniae and" exact="influenza" post="virus infectionJ. Virol.201488134101341710.1128/JVI.01205-1425210171 210.ShinyaK.FujiiY.ItoH.ItoT.KawaokaY.Characterization of a neuraminidase-deficient influenza a"/>
  <result pre="pneumoniae and influenza virus infectionJ. Virol.201488134101341710.1128/JVI.01205-1425210171 210.ShinyaK.FujiiY.ItoH.ItoT.KawaokaY.Characterization of a neuraminidase-deficient" exact="influenza" post="a virus as a potential gene delivery vector and"/>
  <result pre="delivery vector and a live vaccineJ. Virol.2004783083308810.1128/JVI.78.6.3083-3088.200414990727 211.MasicA.PyoH.M.BabiukS.ZhouY.An eight-segment swine" exact="influenza" post="virus harboring H1 and H3 hemagglutinins is attenuated and"/>
  <result pre="in pigsJ. Virol.201387101141012510.1128/JVI.01348-1323843633 212.PyoH.M.ZhouY.Protective efficacy of intranasally administered bivalent live" exact="influenza" post="vaccine and immunological mechanisms underlying the protectionVaccine2014323835384210.1016/j.vaccine.2014.04.06524837774 213.HattaY.BoltzD.SarawarS.KawaokaY.NeumannG.BilselP.M2SR, a"/>
  <result pre="and immunological mechanisms underlying the protectionVaccine2014323835384210.1016/j.vaccine.2014.04.06524837774 213.HattaY.BoltzD.SarawarS.KawaokaY.NeumannG.BilselP.M2SR, a novel live" exact="influenza" post="vaccine, protects mice and ferrets against highly pathogenic avian"/>
  <result pre="highly pathogenic avian influenzaVaccine2017354177418310.1016/j.vaccine.2017.06.03928668565 214.SarawarS.HattaY.WatanabeS.DiasP.NeumannG.KawaokaY.BilselP.M2SR, a novel live single replication" exact="influenza" post="virus vaccine, provides effective heterosubtypic protection in miceVaccine2016345090509810.1016/j.vaccine.2016.08.06127595896 215.RimmelzwaanG.F.VerburghR.J.NieuwkoopN.J.BestebroerT.M.FouchierR.A.OsterhausA.D.Use"/>
  <result pre="vaccine, provides effective heterosubtypic protection in miceVaccine2016345090509810.1016/j.vaccine.2016.08.06127595896 215.RimmelzwaanG.F.VerburghR.J.NieuwkoopN.J.BestebroerT.M.FouchierR.A.OsterhausA.D.Use of GFP-expressing" exact="influenza" post="viruses for the detection of influenza virus A/H5N1 neutralizing"/>
  <result pre="miceVaccine2016345090509810.1016/j.vaccine.2016.08.06127595896 215.RimmelzwaanG.F.VerburghR.J.NieuwkoopN.J.BestebroerT.M.FouchierR.A.OsterhausA.D.Use of GFP-expressing influenza viruses for the detection of" exact="influenza" post="virus A/H5N1 neutralizing antibodiesVaccine2011293424343010.1016/j.vaccine.2011.02.08221396410 216.BakerS.F.NogalesA.SantiagoF.W.TophamD.J.Martinez-SobridoL.Competitive detection of influenza neutralizing"/>
  <result pre="detection of influenza virus A/H5N1 neutralizing antibodiesVaccine2011293424343010.1016/j.vaccine.2011.02.08221396410 216.BakerS.F.NogalesA.SantiagoF.W.TophamD.J.Martinez-SobridoL.Competitive detection of" exact="influenza" post="neutralizing antibodies using a novel bivalent fluorescence-based microneutralization assay"/>
  <result pre="217.ChenJ.LeeK.H.SteinhauerD.A.StevensD.J.SkehelJ.J.WileyD.C.Structure of the hemagglutinin precursor cleavage site, a determinant of" exact="influenza" post="pathogenicity and the origin of the labile conformationCell19989540941710.1016/S0092-8674(00)81771-79814710 218.MoorthyN.S.PoongavanamV.PratheepaV.Viral"/>
  <result pre="vaccineJ. Virol.2009835947595010.1128/JVI.00450-0919321619 220.WatanabeT.WatanabeS.KimJ.H.HattaM.KawaokaY.Novel approach to the development of effective H5N1" exact="influenza" post="A virus vaccines: Use of M2 cytoplasmic tail mutantsJ."/>
  <result pre="Virol.2008822486249210.1128/JVI.01899-0718160446 221.HattaY.HattaM.BilselP.NeumannG.KawaokaY.An M2 cytoplasmic tail mutant as a live attenuated" exact="influenza" post="vaccine against pandemic (H1N1) 2009 influenza virusVaccine2011292308231210.1016/j.vaccine.2011.01.02321272601 222.SiL.XuH.ZhouX.ZhangZ.TianZ.WangY.WuY.ZhangB.NiuZ.ZhangC.et al.Generation"/>
  <result pre="as a live attenuated influenza vaccine against pandemic (H1N1) 2009" exact="influenza" post="virusVaccine2011292308231210.1016/j.vaccine.2011.01.02321272601 222.SiL.XuH.ZhouX.ZhangZ.TianZ.WangY.WuY.ZhangB.NiuZ.ZhangC.et al.Generation of influenza A viruses as live"/>
  <result pre="vaccine against pandemic (H1N1) 2009 influenza virusVaccine2011292308231210.1016/j.vaccine.2011.01.02321272601 222.SiL.XuH.ZhouX.ZhangZ.TianZ.WangY.WuY.ZhangB.NiuZ.ZhangC.et al.Generation of" exact="influenza" post="A viruses as live but replication-incompetent virus vaccinesScience20163541170117310.1126/science.aah586927934767 223.NormanlyJ.KleinaL.G.MassonJ.M.AbelsonJ.MillerJ.H.Construction"/>
  <result pre="of Allergy and Infectious DiseasesJ. Infect. Dis.201821834735410.1093/infdis/jiy10329506129 225.SauttoG.A.KirchenbaumG.A.RossT.M.Towards a universal" exact="influenza" post="vaccine: Different approaches for one goalVirol. J.2018151710.1186/s12985-017-0918-y29370862 Figure 1"/>
  <result pre="replication and gene transcription. Figure 2 Production of the inactivated" exact="influenza" post="vaccine (IIV): To prepare IIV, 10–11 days old chicken"/>
  <result pre="then administrated intramuscularly (IM). Figure 3 Generation of the live-attenuated" exact="influenza" post="vaccine (LAIV): The LAIV is produced by co-infection of"/>
 </snippets>
</snippetsTree>
